000 01355 a2200337 4500
005 20250516173331.0
264 0 _c20150330
008 201503s 0 0 eng d
022 _a1369-1635
024 7 _a10.3109/09537104.2013.835040
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBrantl, S Annette
245 0 0 _aActivation of platelets by the endocannabinoids 2-arachidonoylglycerol and virodhamine is mediated by their conversion to arachidonic acid and thromboxane A2, not by activation of cannabinoid receptors.
_h[electronic resource]
260 _bPlatelets
_c2014
300 _a465-6 p.
_bdigital
500 _aPublication Type: Letter; Research Support, Non-U.S. Gov't; Review
650 0 4 _aArachidonic Acids
_xmetabolism
650 0 4 _aBlood Platelets
_xmetabolism
650 0 4 _aCannabinoid Receptor Agonists
_xmetabolism
650 0 4 _aCannabinoids
_xpharmacology
650 0 4 _aEndocannabinoids
_xmetabolism
650 0 4 _aGlycerides
_xmetabolism
650 0 4 _aHumans
650 0 4 _aPlatelet Activation
_xdrug effects
650 0 4 _aReceptors, Cannabinoid
_xmetabolism
650 0 4 _aThromboxane A2
_xmetabolism
700 1 _aKhandoga, Anna L
700 1 _aSiess, Wolfgang
773 0 _tPlatelets
_gvol. 25
_gno. 6
_gp. 465-6
856 4 0 _uhttps://doi.org/10.3109/09537104.2013.835040
_zAvailable from publisher's website
999 _c23149286
_d23149286